Shanghai Kechow Pharma
Shanghai Kechow Pharma is a China-based pharmaceutical company running 3 late-stage cancer trials of tunlametinib, Tunlametinib and HL-085 in melanoma, colorectal cancer and rare cancers of childhood.
Overview
Shanghai Kechow Pharma, based in Shanghai, China, is a pharmaceutical company. Kechow Pharma is a Shanghai-based pharmaceutical company engaged in independent, intellectual-property-driven innovative drug research and development, focused on oncology and free-radical-related diseases. On ClinicalTrials.gov it is the lead sponsor of 3 recruiting or active phase 2 and phase 3 interventional cancer trials (2 in phase 3), testing tunlametinib, Tunlametinib and HL-085 in melanoma, colorectal cancer and rare cancers of childhood. The largest, NCT06008106 (Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma), plans to enrol 165 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyMultitude Therapeutics
Shares Melanoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyShanghai Fosun Pharmaceutical Industrial Development
Shares Rare cancers of childhood (NCI PDQ umbrella) and the tag ctgov-sponsor.
- CompanyGeorgiamune
Shares Melanoma and the tag ctgov-sponsor.
- CompanyVyriad
Shares Melanoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyKrystal Biotech
Shares Melanoma and the tag ctgov-sponsor.
- CompanymAbxience Research S.L.
Shares Melanoma and the tag ctgov-sponsor.
- CompanySTCube
Shares Colorectal cancer and the tag ctgov-sponsor.
- CompanyAura Biosciences
Shares Melanoma and the tag ctgov-sponsor.